BLISSGVS vs PGHL: Stock Comparison

BLISSGVS vs PROCTER & GAMBLE HEALTH LUpdated 2 Jul 26, 4:08 PM ISTNSE & company filings

PROCTER & GAMBLE HEALTH L is the larger company by market capitalisation. BLISSGVS shows faster revenue growth, while PROCTER & GAMBLE HEALTH L shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLISSGVS leads 5; PGHL leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLISSGVSPGHL

Valuation lens

What price are you paying?

Market CapContext only
₹7,092 Cr
₹9,379 Cr
P/E RatioPGHL has the lower reading
51.05x
26.43x
P/B RatioBLISSGVS has the lower reading
5.83x
17.98x
EPSPGHL has the higher reading
₹3.64
₹57.92
Book ValueContext only
₹116.14
₹316.01
Dividend YieldPGHL has the higher reading
0.22%
3.45%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PGHL is the larger company
₹9,379 Cr vs ₹7,092 Cr
P/E Ratio
PGHL has a lower P/E
26.43x vs 51.05x
P/B Ratio
BLISSGVS has a lower P/B
5.83x vs 17.98x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹3.64
Dividend Yield
PGHL has a higher dividend yield
3.45% vs 0.22%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs 19.1%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 54.6%
Qtr Sales Growth
BLISSGVS has stronger quarterly sales growth
-22.41% vs -74.17%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSPGHL
Live Price₹527.1₹5,660
Day Change0.68%-1.69%
Volume3.93 L7,255
52-Week High₹553₹6,975
52-Week Low₹118₹4,707
Distance from 52W High-4.68%-18.85%

Valuation

MetricBLISSGVSPGHL
Market Cap₹7,092 Cr₹9,379 Cr
P/E Ratio51.05x26.43x
P/B Ratio5.83x17.98x
EPS₹3.64₹57.92
Book Value₹116.14₹316.01
Dividend Yield0.22%3.45%

Growth

MetricBLISSGVSPGHL
Revenue Growth (TTM YoY)29.8%19.1%
EPS Growth (TTM YoY)124.7%54.6%
Qtr Sales Growth-22.41%-74.17%
Qtr Profit Growth-24.83%-70.59%

Profitability & Leverage

MetricBLISSGVSPGHL
ROE8.39%62.32%
ROCE9.11%92.1%
Net Margin13.93%23.22%
Operating Margin19.81%31.99%
Debt to Equity0x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLISSGVSPGHL
Promoter Holding35.01% 0.35 pp0%
FII Holding8.07% 2.38 pp6.33% 0.13 pp
DII Holding9.47% 4.43 pp12.44% 1.23 pp
Public Holding47.45% 1.7 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLISSGVS and PROCTER & GAMBLE HEALTH L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.